MSTN and obesity due to melanocortin 4 receptor deficiency: The introduction of MSTN protein-like molecules and the manipulation of endogenous MSTN levels also offer potential means for preventing or treating metabolic ailments like muscle wasting, type 2 diabetes, and obesity [57].